Polymorphic markers of prostate carcinoma tumor antigen-1(PCTA-1)
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 6, 2004
Grant Date -
N/A
app pub date -
Jun 4, 1999
filing date -
Jun 5, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention concerns the geNo.mic sequence and cDNA sequences of the PCTA-1 gene. The invention also concerns biallelic markers of the PCTA-1 gene and the association established between these markers and prostate cancer. The invention provides means to determine the predisposition of individuals to prostate cancer as well as means for the diagNo.sis of prostate cancer and for the progNo.sis/detection of an eventual treatment response to agents acting against prostate cancer.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully